Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A detailed review of FDA Adverse Event Reporting System (FAERS) data for generic sildenafil 20-100 mg, covering the most reported safety signals, serious adverse events, and what the post-market record means for prescribers and patients.
Read clinical reviewA comprehensive regulatory guide to generic sildenafil covering FDA approval history, EMA authorization, global OTC reclassification, label requirements, and post-market safety surveillance data.
Read clinical reviewA detailed review of the legal battles, patent disputes, and regulatory milestones that shaped generic sildenafil availability in the United States and globally.
Read clinical reviewA clinical overview of generic sildenafil's regulatory history, current FDA-approved formulations, pipeline developments, and next-generation delivery systems for erectile dysfunction and pulmonary arterial hypertension.
Read clinical reviewHow the FDA and EMA each regulate generic sildenafil, from bioequivalence standards and labeling differences to post-market surveillance frameworks. Evidence-based comparison for clinicians and patients.
Read clinical review